Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Accounts Payables (2023 - 2025)

Historic Accounts Payables for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $1.8 million.

  • Onconetix's Accounts Payables fell 5612.86% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 5612.86%. This contributed to the annual value of $3.8 million for FY2024, which is 2847.06% down from last year.
  • According to the latest figures from Q3 2025, Onconetix's Accounts Payables is $1.8 million, which was down 5612.86% from $2.6 million recorded in Q2 2025.
  • Onconetix's 5-year Accounts Payables high stood at $5.3 million for Q4 2023, and its period low was $1.5 million during Q1 2023.
  • Its 3-year average for Accounts Payables is $3.1 million, with a median of $3.2 million in 2024.
  • Per our database at Business Quant, Onconetix's Accounts Payables surged by 18281.12% in 2024 and then crashed by 5612.86% in 2025.
  • Over the past 3 years, Onconetix's Accounts Payables (Quarter) stood at $5.3 million in 2023, then dropped by 28.47% to $3.8 million in 2024, then tumbled by 52.37% to $1.8 million in 2025.
  • Its Accounts Payables stands at $1.8 million for Q3 2025, versus $2.6 million for Q2 2025 and $2.6 million for Q1 2025.